A planned treatment holiday is a feasible option for patients with metastatic prostate cancer who achieve a deep response to modern ARPI and ADT therapies, a multi-year analysis of patient outcomes has found.
Emma Koehn is a journalist at various esteemed publications, including The Sydney Morning Herald and Brisbane Times. She focuses on medicine and healthcare, covering a range of topics such as consumer health, public health, and healthcare technology, with particular interests in medical specialties like endocrinology and oncology. Emma's work has been featured in notable outlets including SmartCompany and the Australian Computer Society.